Printer Friendly

Beckman Coulter Announces New Contract with Orlando Regional Health Care Systems.

BREA, Calif.--(BW HealthWire)--Nov. 18, 1999--

Beckman Coulter, Inc. (NYSE:BEC) today announced that the company is providing clinical diagnostics instrumentation for six hospital systems within the Orlando Regional Health Care Systems -- a contract representing more than $5 million over the next five years.

Under the terms of the agreement, Beckman Coulter is currently installing one (1) SYNCHRON LX(R)4201 clinical chemistry system, one (1) SYNCHRON LX20, three (3) SYNCHRON CX(R)9 ALX clinical systems, three (3) SYNCHRON CX3 clinical systems, one (1) ChemExpress modular automation workstation, reagents and supplies.

Recipients of the equipment are core laboratory Orlando Regional Health Care, South Seminole, Sand Lake, St. Cloud, M.D. Anderson and Ovida Clinic.

"We had several objectives when we started this project more than two years ago," said Cindy Kuehn, Director of Laboratories for ORHS. "We wanted workstation consolidation, the ability to eliminate redundancy and the most efficient instrumentation for Orlando Regional Medical Center and the Community Hospital Laboratories, the flexibility to automate lab processes and the ability to reduce suppliers and operating costs while expanding our test menu. We selected Beckman Coulter because it met or exceeded all those objectives."

After successful installation of all instruments, the health system claims it will consider additional acquisitions of a Hematology and Immunology product solution from Beckman Coulter.

Orlando Regional Health Care System, a rapidly growing health care network, is part of the Central Florida Alliance and has recently purchased Lucerne Medical Center.

According to Jeff McHugh, Vice President, Director of NAO Field Operations for Beckman Coulter, "This health system is extremely influential in their purchase decisions and is a very positive reference for us. They are now on-line with most instruments and are currently preparing for the installation of the ChemExpress. They are confident they have entered into a business partnership that is a win-win relationship."

Beckman Coulter, Inc. is a leading provider of instrument systems and complementary products that simplify and automate processes in life science and clinical laboratories. The company's products are used throughout the world in all phases of the battle against disease, from pioneering medical research and drug discovery to diagnostic testing that aids in patient treatment. Annual sales for the company totaled $1.7 billion in 1998, with approximately half of this amount generated outside the United States.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Nov 18, 1999
Previous Article:Penn State and Geisinger to Restructure Relationship.
Next Article:Humana's Military Subsidiary Offers Online Interactive Reporting; TRICARE Providers Access Information Online.

Related Articles
Beckman Coulter Announces New Contract with MHA Group Purchasing Organization.
Beckman Coulter Wins Contract with Novation for its Access Immunochemistry System and Select Chemistries.
Beckman Coulter Announces 1999 Results.
Beckman Coulter Expands Contract With Novation for Entire Menu of Access Immunoassay System Chemistries.
Beckman Coulter and Novation Extend Chemistry Agreement Valued at $144 Million.
Beckman Coulter Signs $104 Million in Hospital Network Agreements During Fourth Quarter 2001; Record $196.5 Million in Network Agreements Signed in...
Beckman Coulter and Premier Sign Agreements Valued at $173 Million for Comprehensive Medical Diagnostic Products.
Beckman Coulter Signs $77.5-Million Agreement with MedAssets to Supply Automation and Chemistry Products.
Beckman Coulter Signs Contract with HealthTrust Purchasing Group to Provide Chemistry Systems and Supplies.
Beckman Coulter and AmeriNet Renew $60 Million Immunoassay Agreement.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters